Funds and ETFs Merck & Co., Inc.

Equities

MRK

US58933Y1055

Pharmaceuticals

Market Closed - Nyse 01:30:02 30/05/2024 am IST After market 02:18:24 am
125.9 USD -0.15% Intraday chart for Merck & Co., Inc. 126 +0.05%

ETFs positioned on Merck & Co., Inc.

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
126.1 USD
Average target price
141.9 USD
Spread / Average Target
+12.52%
Consensus
1st Jan change Capi.
+15.48% 32TCr
+39.22% 73TCr
+30.57% 59TCr
-7.85% 35TCr
-0.12% 27TCr
+12.55% 24TCr
+6.65% 20TCr
-6.09% 20TCr
-3.37% 16TCr
-2.28% 12TCr
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. MRK Stock
  4. Funds and ETFs Merck & Co., Inc.